Oral administration of 1,4-dihydroxy-2-naphthoic acid (DHNA), an AHR activator derived from the cheese bacteria Propionibacterium freudenreichii ET-3, induced anti-microbial peptides in the intestine, further controlling inflammation in DSS-colitis [262]. This evidence concerns the gene AHR and colitis.